HomeCompareKBRS vs CL

KBRS vs CL: Dividend Comparison 2026

KBRS yields 166.67% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KBRS wins by $23.6K in total portfolio value
10 years
KBRS
KBRS
● Live price
166.67%
Share price
$1.20
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.5K
Annual income
$53.35
Full KBRS calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — KBRS vs CL

📍 KBRS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKBRSCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KBRS + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KBRS pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBRS
Annual income on $10K today (after 15% tax)
$14,166.67/yr
After 10yr DRIP, annual income (after tax)
$45.35/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, CL beats the other by $4,588.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBRS + CL for your $10,000?

KBRS: 50%CL: 50%
100% CL50/50100% KBRS
Portfolio after 10yr
$52.8K
Annual income
$2,752.52/yr
Blended yield
5.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

KBRS
No analyst data
Altman Z
19.7
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBRS buys
0
CL buys
9
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$CL▼ Sell$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-10-07
Rick Larsen🏢 House$CL▼ Sell$1,001 - $15,0002025-10-06
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CL▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CL▼ Sell$1,001 - $15,0002025-09-11
Tim Moore🏢 House$CL▼ Sell$1,001 - $15,0002025-09-10
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-08-26
Lisa McClain🏢 House$CL▲ Buy$1,001 - $15,0002025-08-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKBRSCL
Forward yield166.67%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28.6%
Portfolio after 10y$64.5K$41.0K
Annual income after 10y$53.35$5,451.69
Total dividends collected$27.0K$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: KBRS vs CL ($10,000, DRIP)

YearKBRS PortfolioKBRS Income/yrCL PortfolioCL Income/yrGap
1← crossover$19,033$8,333.33$11,014$313.84+$8.0KKBRS
2$27,777$7,411.73$12,200$415.44+$15.6KKBRS
3$34,776$5,054.55$13,607$553.09+$21.2KKBRS
4$40,168$2,957.07$15,301$741.41+$24.9KKBRS
5$44,576$1,596.03$17,374$1,002.00+$27.2KKBRS
6$48,524$827.65$19,958$1,367.44+$28.6KKBRS
7$52,341$421.01$23,243$1,887.87+$29.1KKBRS
8$56,217$212.21$27,512$2,642.43+$28.7KKBRS
9$60,259$106.51$33,197$3,759.22+$27.1KKBRS
10$64,530$53.35$40,973$5,451.69+$23.6KKBRS

KBRS vs CL: Complete Analysis 2026

KBRSStock

KBS Real Estate Investment Trust II, Inc. was formed on July 12, 2007 as a Maryland corporation that elected to be taxed as a real estate investment trust beginning with the taxable year ended December 31, 2008. The Company conducts its business primarily through KBS Limited Partnership II, a Delaware limited partnership formed on August 23, 2007, and its subsidiaries. The Company is the sole general partner of and directly owns a 0.1% partnership interest in the Operating Partnership. The Company's wholly-owned subsidiary, KBS REIT Holdings II LLC, a Delaware limited liability company formed on August 23, 2007, owns the remaining 99.9% partnership interest in the Operating Partnership and is its sole limited partner. As of September 30, 2020, the Company owned four office properties and an office campus consisting of two office buildings. Subject to certain restrictions and limitations, the business of the Company is managed by KBS Capital Advisors LLC. On November 13, 2019, in connection with a review of potential strategic alternatives available to the Company, a special committee composed of all of the Company's independent directors and the board of directors unanimously approved the sale of all of the Company's assets and the dissolution of the Company pursuant to the terms of the plan of complete liquidation and dissolution. The principal purpose of the Plan of Liquidation is to provide liquidity to the Company's stockholders by selling the Company's assets, paying its debts and distributing the net proceeds from liquidation to the Company's stockholders. On March 5, 2020, the Company's stockholders approved the Plan of Liquidation.

Full KBRS Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this KBRS vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBRS vs SCHDKBRS vs JEPIKBRS vs OKBRS vs KOKBRS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.